AI/ML
November 20, 2025
As AI reshapes how healthcare providers learn, diagnose, and make decisions, one principle remains constant: better inputs drive better outcomes. At Relevate Health, our approach to AI-driven HCP engagement starts with the strongest input possible: real-world behavioral data.
Through our Treatment Perspectives® Network, built on 15+ years of HCP behavior insights, we’ve captured millions of signals that reveal how clinicians learn, prescribe, and respond to information. This gives us a clearer, more complete picture than traditional demographic or claims-based targeting alone.
What sets our data apart is its dynamic nature. HCPs change behavior every day: new scripts are written, new content is consumed, and new clinical questions emerge. Our models update alongside those shifts, ensuring that AI-powered targeting and messaging are grounded in what providers are doing now, not what they did last year.
This behavioral intelligence enables:
Precision targeting based on real actions, not static lists or outdated personas
More timely and relevant engagement, delivered at both moments that matter: the point of learning and the point of clinical decision
Closed-loop optimization, where campaigns are refined based on demonstrated behavior change—because impact matters more than impressions
For pharmaceutical marketers, this translates into smarter HCP activation, more confident strategic decisions, and visibility into the clinical impact of their efforts.
For HCPs, it means receiving information that supports real-world challenges, delivered when they’re most receptive and when it can most influence care.
As AI accelerates across healthcare, the differentiator won’t be who uses it—it will be who feeds it the most meaningful data, and behavioral intelligence is the foundation.
